This webinar introduces key updates in acute ischemic stroke management, focusing on how modern decision‑making integrates time‑sensitive evaluation, advanced imaging, and AI‑supported tools. It also reviews the expanded…
Pompe disease is a rare, life-threatening genetic disorder caused by GAA enzyme deficiency, leading to glycogen buildup and muscle cell destruction. It presents on a spectrum, from infantile-onset…
NEW YORK (Reuters Health) – Symptoms of posttraumatic stress disorder (PTSD) appear to increase the long-term mortality rate in patients with implantable cardioverter defibrillators (ICDs), according to a…
NEW YORK (Reuters Health) – Once elderly patients are diagnosed with Alzheimer’s disease, ethnicity and comorbidity appear to affect survival, investigators report in the November 4 issue of…
NEW YORK (Reuters Health) – As a treatment for early multiple sclerosis, alemtuzumab, an antibody that targets CD52 on lymphocytes and monocytes, is more effective than interferon beta-1a,…
NEW YORK (Reuters Health) – Encephalitis caused by human herpesviruses may trigger acute retinal necrosis, even years after the initial illness, Dutch investigators report in the October 14…
NEW YORK (Reuters Health) – Following transcatheter closure of a patent foramen ovale (PFO), migraine relief may occur despite residual right-to-left shunt, researchers report in the October 1st…
NEW YORK (Reuters Health) – Detection of JC virus, an important cause of progressive multifocal leukoencephalopathy (PML) in immunosuppressed patients, is not a good predictor of PML risk…
NEW YORK (Reuters Health) – Patients aged 75 years and older with brain metastases respond about as well as younger patients to stereotactic radiosurgery (SRS), according to a…
NEW YORK (Reuters Health) – Even in the absence of clinical stroke, atrial fibrillation (AF) is associated with impaired cognitive function and reduced hippocampal volume, according to findings…
